Gautam J et al. |
An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. |
2016 |
J. Pharm. Pharmacol. |
pmid:27265669
|
Owen S et al. |
Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. |
2016 |
Int. J. Oncol. |
pmid:26781475
|
Maser RE et al. |
Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. |
2016 |
J. Diabetes Complicat. |
pmid:26775555
|
Wang HL et al. |
Protein biomarkers and microbial profiles in peri-implantitis. |
2016 |
Clin Oral Implants Res |
pmid:26424287
|
Kainuma S et al. |
Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts. |
2016 |
Mol Med Rep |
pmid:26935864
|
Biscetti F et al. |
RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. |
2016 |
Eur Rev Med Pharmacol Sci |
pmid:27874938
|
Liu FQ et al. |
Effects of Salt Loading on Plasma Osteoprotegerin Levels and Protective Role of Potassium Supplement in Normotensive Subjects. |
2016 |
Circ. J. |
pmid:27867157
|
Yamada C et al. |
TGF-β in jaw tumor fluids induces RANKL expression in stromal fibroblasts. |
2016 |
Int. J. Oncol. |
pmid:27279422
|
He M et al. |
Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. |
2016 |
Mol Med Rep |
pmid:27277157
|
Ye C et al. |
[Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. |
2016 |
Hua Xi Kou Qiang Yi Xue Za Zhi |
pmid:27266195
|